MLYS Stock-Based Compensation

Mineralys Therapeutics Inc · Stock-Based Compensation

MLYS logo

MLYS Stock-Based Compensation

Latest reported$25.03M
MLYS TTM Stock-Based Comp ($253.00K → $25.03M)
High-resolution chart · PNG

MLYS stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Mineralys Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
25,029,000
22,227,000
19,324,000
17,173,000
14,471,000
9,920,872
8,466,872
6,789,872
5,228,872
6,502,000
5,060,000
3,821,000
2,435,000
1,185,000
455,000
253,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.